 (Arch Dis Child 1997;76:526-528) 
The Guillain-Barré syndrome (GBS) is the most common cause of acute neuromuscular paralysis. Although GBS has been associated with a wide variety of preceding infections, campylobacter infections appear to be the most common preceding event, with evidence of infection in up to 38% of adults with GBS. 1 2 There have been a few reports of an association of childhood GBS and campylobacter infection. [3] [4] [5] At the Red Cross War Memorial Children's Hospital (RCWMCH) in Cape Town, an average of 10 cases of GBS have been seen each year since 1975. During the period June 1994 to August 1995 a total of 23 children with GBS were seen at the hospital, of whom 17 were admitted to the intensive care unit. This paper reports the associations between campylobacter infection and GBS in these patients.
Patients and methods
Stool specimens were collected from patients admitted to the intensive care unit at RCW-MCH between June 1994 and August 1995 with clinical features of GBS. Patients were included in the study if they fulfilled the diagnostic criteria for acute GBS as published by Asbury and Cornblath. 6 Clinical data were obtained from a retrospective analysis of the patients' charts.
ISOLATION AND GROWTH
All stool specimens were cultured by established methods. Gram negative motile, spiral, or curved rods were cultured on tryptose blood agar plates (CM233, Oxoid Ltd) containing 10% v/v unlysed horse blood. Culture plates were incubated at 37°C under microaerophilic (12% carbon dioxide, 88% air, and 95% humidity) growth conditions.
BIOTYPING AND SEROTYPING
Identification was accomplished by established tests and all isolates were biotyped by the scheme of Skirrow and Benjamin. 7 Serotyping on the basis of thermostable somatic (O) lipopolysaccharide antigens was performed with the 66 antisera of the Penner scheme. 8 Isolates were also serotyped against an additional 30 antisera to new serotypes not included in this scheme.
Results
Over a period of 15 months, 17 children aged 14-108 (median 47) months were admitted to the intensive care unit of the RCWMCH in Cape Town with GBS (table 1) .
Campylobacter species were isolated from nine of the 14 patients from whom stool specimens were obtained. Six of these isolates were identified as C jejuni biotype 2, serotype 0:41. The other three campylobacter isolates were C concisus, C upsaliensis, and C jejuni biotype 1.
Before presentation with GBS only three of the nine patients with a positive campylobacter culture had a history of a preceding diarrhoeal illness, four had had a preceding upper respiratory tract infection, and two had no prior infection.
The GBS in patients with campylobacter isolates was more severe than in patients with negative stool cultures. Eight of the nine patients with campylobacter isolates and one of five patients with negative stool cultures required ventilation (p< 0.05) with a mean duration of ventilation of 28.1 days. The duration of admission to hospital was also prolonged in patients with campylobacter (mean 43 v 9.8 days, p< 0.01). Only one patient who was ventilated for more than 20 days had a negative stool culture for campylobacter isolates. One patient from whom no stool was collected was ventilated for more than 20 days.
Among patients with campylobacter isolates, those with C jejuni biotype 2, serotype 0:41 had more severe disease. Overall, patients with C jejuni biotype 2, serotype 0:41 were ventilated for 33.5 (95% confidence interval (CI) 13.1 to 54.0) days, whereas patients with other campylobacter isolates were ventilated for 17.3 (95% CI 7.9 to 26.7) days. The length of stay in hospital was also prolonged for patients with C jejuni biotype 2, serotype 0:41 at 50.8 days (95% CI 34.6 to 67.1) v 27.3 days (95% CI 14.6 to 40.0). There was no diVerence in age between the groups of patients.
Discussion
The RCWMCH is one of two referral hospitals serving a population of three million people, 40% of whom are under the age of 14 years. 9 GBS is said to occur at a rate of 0.6-1.1 cases per 100 000 children under 15 years of age each year, 10 suggesting that 12 children should present each year. To have approximately 10 patients with severe disease admitted to the intensive care unit each year suggests that a severe form of the disease is seen in this area. The age of the children is also unusually low for this severity of disease. A retrospective multicentre review of paediatric patients with GBS described a bimodal distribution of age, with peaks at 4 and 12 years, and severe disease was found predominantly in older children. 11 It is possible that children in the older group are seen at adult units and not referred to the paediatric hospital.
Our patients with campylobacter associated GBS (CAGBS) had a particularly severe form of GBS with a high requirement for (eight of nine) and duration of (mean 28.1 days) ventilation. By contrast, only one of 23 children with GBS reported by Briscoe et al 12 required ventilation, as did 16% of patients reported by Korinthenberg and Schulte Monting. 11 In a report of 11 paediatric patients with severe GBS, 13 the nine patients who survived were ventilated for a median of 18 days, whereas the median duration of ventilation reported in a multicentre study was 10 days.
11
Our patients with CAGBS were younger than those previously described, with the exception of the patients reported by De Bont et al (2 years) 3 and Sugita et al (4 years).
5
Patients reported by Kuroki et al were aged 7-14 years (median 11 years), 4 whereas Yuki et al reported two patients aged 13 and 9 years with Miller-Fisher syndrome associated with campylobacter. 14 The proportion of preceding gastrointestinal symptoms in our patients with CAGBS is similar to other studies of CAGBS where diarrhoea was noted in four of nine 4 and 19 of 27 patients. 15 Patients with CAGBS from whom C jejuni biotype 2, serotype 0:41 was isolated had a particularly severe form of GBS requiring ventilation and admission to hospital for a mean of 33.5 and 50.8 days, respectively. It is possible that the two patients (one with no stool isolate of campylobacter and one with no stool culture) with severe disease and no evidence of campylobacter infection had had recent infection as the organisms are not always found in stools at the time of presentation. 16 Of the seven patients with CAGBS (four of these had serotype 0:19) reported by Kuroki et 18 19 and Lior biotype 11. 20 The incidence of serotype 0:19 in campylobacter stool isolates seen at RCWMCH is <3% and GBS was not recognised in patients with this serotype.
Previous studies have suggested that there is an association between the development of GBS and the presence of antibodies to ganglioside GM M1 . 5 21-23 Several studies have suggested that there are similarities between the lipopolysaccharide structures of campylobacter and human gangliosides. 24 25 Of particular interest is evidence that lipopolysaccharides extracted from C jejuni of serotype 0:19 and 0:4 had core oligosaccharides with terminal structures resembling human gangliosides G M1 and G D1a . 26 To date, there is no published data about the lipopolysaccharide structures of C jejuni biotype 2, serotype 0:41 and this should be studied further.
We did not perform nerve conduction studies in these patients and thus do not know whether our patients had patterns of acute inflammatory demyelinating polyneuropathy or acute motor axonal neuropathy. 27 It is impractical to treat patients with C jejuni positive stools with antibiotics to prevent the rare complication of GBS. Previous studies have suggested that treatment of patients with campylobacter associated GBS does not prevent the development of GBS.
2 3 28 It may be worth investigating the possibility that early treatment with erythromycin may shorten the duration of the illness, however. Although treatment with erythromycin does not aVect the natural course of campylobacter enteritis, it does clear campylobacter from stools. In two studies of acute campylobacter enteritis erythromycin cleared campylobacter from the stools of all 28 patients within two days, and in a study of 10 convalescent excretors erythromycin treatment cleared the stool within 48 hours. 29 Thus erythromycin does clear the organism and if there is a cross reaction with molecular mimicry between campylobacter and the central nervous system, clearance of the organism and reduction of the antigen load may make a diVerence to the clinical course of the patients.
Conclusions
We have documented the association of a severe form of GBS in children with concurrent infection with campylobacter species and particularly with C jejuni biotype 2, serotype 0:41 (an extremely rare serotype in this community). This highlights the importance of campylobacter infection as a possible cause of GBS and raises further possible directions for the treatment and investigation of pathogenetic mechanisms of GBS.
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